Skip to main content

nicotine lozenge

NDC 37808-674 · H E B

Generic namenicotine polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength2 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

37808-674-03 — 1 CONTAINER in 1 CARTON (37808-674-03) / 24 LOZENGE in 1 CONTAINER

37808-674-10 — 4 CONTAINER in 1 CARTON (37808-674-10) / 27 LOZENGE in 1 CONTAINER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

36800-957 — Nicotine Polacrilex, 36800-967 — nicotine polacrilex, 37808-383 — nicotine, 37808-460 — Nicotine Transdermal System, 37808-461 — Nicotine Transdermal System, 37808-533 — nicotine, 37808-563 — Nicotine Polacrilex, 37808-611 — nicotine polacrilex, 37808-617 — nicotine polacrilex, 37808-658 — nicotine polacrilex, 37808-682 — nicotine, 37808-683 — nicotine polacrilex, 37808-707 — nicotine, 37808-711 — nicotine, 37808-739 — nicotine, 37808-781 — nicotine polacrilex, 37808-820 — Nicotine Polacrilex, 37808-821 — Nicotine Polacrilex, 37808-849 — nicotine polacrilex, 37808-863 — nicotine polacrilex, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels